Lv1
70 积分 2021-10-29 加入
Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer
2个月前
已完结
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
2个月前
已完结
Nonoperative Management of Mismatch Repair–Deficient Tumors
2个月前
已完结
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)
2个月前
已完结
Preoperative Short-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor Administration for Locally Advanced Rectal Cancer: The Initial Results of a Randomized Phase II/III Trial (STELLAR II study)
2个月前
已完结
NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancer
2个月前
已完结
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bm0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study
2个月前
已完结
Neoadjuvant Treatment of Mismatch Repair–Deficient Colon Cancer — Clinically Meaningful?
2个月前
已完结
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
2个月前
已完结
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
2个月前
已完结
皖公网安备34019202002308
